Phase II study of vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in patients with advanced transitional cell urothelial cancer (TCC) after platinum-based therapy—California Cancer Consortium/University of Pittsburgh NCI/CTEP-sponsored trial
2008
16058 Background: There is no defined standard second-line therapy for patients (pts) with advanced TCC. Histone deacetylase inhibitors (HDACi) have anti-cancer activity in a variety of models incl...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
21
Citations
NaN
KQI